New vaccine will stop the spread of bovine TB

Scientists at the University of Surrey have developed a novel vaccine and complementary skin test to protect cattle against bovine tuberculosis (bovine TB). Publishing their findings in the journal Scientific Reports, researchers reveal they have for the first time created a vaccine that is compatible with a synthetic form of the tuberculin skin test (PPD),…

Activation of opioid receptor uncovered

Together with colleagues from Shanghai, Brussels, Canada and the USA, researchers from the University of Bonn have uncovered the binding mechanism of an important pain receptor. The results facilitate the development of new active substances. The opioids used today to treat severe pain can be addictive and sometimes have life-threatening side effects. The results are…

Black silicon can help detect explosives

Scientists from Far Eastern Federal University (FEFU), Far Eastern Branch of the Russian Academy of Sciences, Swinburne University of Technology, and Melbourne Center for Nanofabrication developed an ultrasensitive detector based on black silicon. The device is able to detect trace amounts of nitroaromatic compounds and can be applied to identify the majority of explosives or…

Loyola launches study on pelvic floor dysfunction in female athletes

MAYWOOD, IL – A multidisciplinary team at Loyola Medicine is launching a clinical research study to determine the most prevalent factors impacting young women’s pelvic health. The study, which includes a team of researchers in Urogynecology, epidemiology and public health, urology, physical medicine and rehabilitation, sports medicine and biostatistics, will be investigating how sports participation,…

New study shows a minimum dose of hydromethylthionine could slow cognitive decline

ABERDEEN, Scotland and Singapore, 26 November, 2019 – In a paper published in today’s online issue of the Journal of Alzheimer’s Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients…

NewPneu, a cost-effective system for diagnosing childhood pneumonia in low-res

Oakville, Ontario: A device designed by a team of faculty and student researchers at Sheridan’s Centre for Mobile Innovation (CMI) has the potential to impact the diagnosis of community-acquired pneumonia – a significant cause of death for children worldwide, according to the World Health Organization. NewPneu is a mobile health solution that’s cost-effective, portable, easy…